The S&P/ASX Small Ordinaries Index (ASX: XSO) slipped 43.7 points, or 1.25%, to close at 3,461.5 yesterday and has eased a further 5.1 points, or 0.15%, over the past five trading days as investors continued to weigh risk sentiment across the small-cap sector.
Despite the softer broader market performance, several junior explorers have delivered operational updates this morning, highlighting drilling progress, resource expansion potential and new exploration targets across gold, rare earths and critical minerals projects.
Amneal Pharmaceuticals (NASDAQ:AMRX) said on Thursday the US Food and Drug Administration has approved its romidepsin injection solution, 27.5 mg/5.5 mL, in single-dose, ready-to-use vials.
The product is eligible for Competitive Generic Therapy (CGT) designation, giving Amneal 180 days of market exclusivity. The New Jersey-based company said it has received more CGT approvals than any other company since the FDA began tracking the designations in 2018.
AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) has kept Jefferies analysts bullish on the company following a fireside chat in New York City, with the firm reiterating a 'Buy' rating and a $10 price target on the company, implying roughly 120% upside from current levels.
The firm’s outlook centers on strengthening late-stage visibility across the company’s psychedelic pipeline and what it described as an increasingly constructive regulatory backdrop.
Plus Therapeutics Inc (NASDAQ:PSTV) said its CNSide Diagnostics unit has received accreditation from the College of American Pathologists, a widely recognized standard in laboratory quality, sending shares of the Nasdaq-listed company up 8.7% to $5.89 Thursday.
CNSide Diagnostics' Houston-based clinical laboratory underwent a rigorous on-site inspection evaluating clinical protocols, documentation, quality control procedures, personnel qualifications, equipment, facilities, and overall laboratory management. The lab now joins more than 8,000 CAP-accredited facilities worldwide.
U.S. Energy Corp. (NASDAQ:USEG) has officially changed its corporate name to Big Sky Industrial Inc, as the Houston-based company repositions around helium production and carbon management.
The company will now trade under the ticker symbol BSIN, effective June 8.
Trillion Energy International Inc. (CSE:TCF, OTCQB:TRLEF, FRA:Z620) is stepping up its push into an underexplored onshore oil block in southeastern Türkiye, making a second cash payment of US$250,000 toward its earn-in obligations on the M47c,d Concession as it prepares an upcoming seismic program expected to unlock new drilling targets.
The payment brings total earn-in payments to US$500,000 against the company's US$9.5 million work program commitment, through which it is earning a 29% participating interest in the block, located in the Cudi-Gabar petroleum province.
Petco Health and Wellness Co (NASDAQ:WOOF) reported a wider-than-expected net loss in its first quarter even as revenue edged past estimates, sending shares down nearly 13% in premarket trading Thursday.
The pet retailer posted net sales of $1.5 billion for the quarter ended May 2025, up 0.2% year-over-year and slightly above the $1.49 billion analysts had forecast.
Gunnison Copper Corp (TSX:GCU, OTCQB:GCUMF, FRA:3XS0) has announced plans for a district-wide drilling program at its Gunnison copper project, including the Strong & Harris satellite deposit, in Arizona's Cochise Mining District.
The company said the program has been fully contracted and committed, with drill rig mobilization expected to begin this month.
Longspur Research has initiated coverage of Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S), the battery materials company, with a central case valuation of 153p per share, representing nearly eight times the current share price of 19.25p.
The broker's bullish case rests on Gelion's proprietary nano-encapsulated sulfur cathode active material, a technology it says can produce batteries that outperform conventional lithium-ion chemistries while costing less to manufacture, even when made in the West.
Tertiary Minerals PLC (AIM:TYM, OTC:TTIRF, FRA:TMU), the explorer focused on energy transition and precious metals, has raised £1 million through a share placing to fund drilling at its Zambian silver discovery.
The company issued 1.97 billion new ordinary shares at 0.05 pence each, raising £985,000 before expenses, with two directors intending to subscribe for a further £15,000 of shares once the company exits a close period ahead of interim results due before the end of June.
Graphene was once marketed as a breakthrough material capable of improving almost everything. As the industry moves from laboratory testing into commercial deployment, a different challenge is emerging: not whether graphene works, but how best to use it.
According to First Graphene Ltd (ASX:FGR, OTCQB:FGPHF, FRA:M11) managing director Michael Bell, that means a shift towards tailoring graphene materials to the needs of individual industries and manufacturing processes.
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) will host a virtual investor briefing on Thursday, June 11, at 10:30am AEST to provide an update on the US commercialisation of FebriDx® following FDA CLIA waiver clearance.
Director of US Sales Tommy Hall and PHASE Scientific vice president of commercial operations Bob Gergen will outline progress since CLIA waiver status was received, including the rollout of FebriDx across more than 100 healthcare locations in 18 US states.
First Graphene Ltd (ASX:FGR, OTCQB:FGPHF, FRA:M11) has struck a deal to acquire the assets, intellectual property and product portfolio of US-based MITO Material Solutions, a move that significantly broadens its graphene technology offering while establishing a direct commercial platform in the world's largest advanced materials market.
First Graphene will acquire MITO's product lines, manufacturing equipment, client agreements and intellectual property under an agreement valued at A$850,000, comprising A$275,000 in cash and up to A$575,000 in performance-linked shares.
Elixir Energy Ltd (ASX:EXR, OTC:ELXPF) has started the next phase of work at its high-impact Lorelle-3H appraisal well in ATP2056 in Queensland’s Taroom Trough, with a Diagnostic Fracture Injection Test (DFIT) now underway.
The DFIT, being conducted with Halliburton at the toe end of the horizontal well, is designed to measure reservoir pressure in the Tinowon ‘Dunk’ Sandstone and gather data to support the final design of the multi-stage stimulation and testing program.
AuMEGA Metals Ltd (ASX:AAM, TSX:AUM, OTCQB:AUMMF, FRA:FRA: MA30) has mobilised field crews to southwestern Newfoundland and Labrador, kicking off a major 2026 exploration campaign that will lead into diamond drilling at priority gold and critical minerals targets along the Cape Ray Shear Zone.
